Kannalife_logo_w-Tag.png
Kannalife, Inc. Receives Patent Grants in Additional European Territories
25 août 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development...
Kannalife_logo_w-Tag.png
Kannalife, Inc. Bolsters IP Portfolio with Multiple Patents Issued in 12 Key European Territories
30 juin 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., June 30, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development...
Kannalife_logo_w-Tag.png
Kannalife, Inc. Appoints Terrence O. Tormey to the Company’s Board of Advisors
02 juin 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
Kannalife, Inc. CEO Op-Ed Featured in Green Entrepreneur Magazine’s Latest Edition
28 avr. 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., April 28, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
Kannalife, Inc. CEO Featured in OTCQB Podcast Discussing KLS-13019 and Its Potential Role as a Non-Opioid Treatment for Neuropathic Pain
16 avr. 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., April 16, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
Kannalife, Inc. Announces Results from Comparative UVB-Radiation Study on Atopidine™ Versus CBD
14 avr. 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., April 14, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
UPDATE – Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™
01 avr. 2020 11h23 HE | Kannalife, Inc.
DOYLESTOWN, Pa., April 01, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
Kannalife, Inc. Receives Seventh Patent by Extending Patent Family to Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders
18 mars 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical med-chem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
Kannalife, Inc. Receives Patent in the European Union (EU) for its Novel Monotherapeutic Compound to Treat CNS and PNS Disorders
03 mars 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical med-chem company specializing in the research and development of...
Kannalife_logo_w-Tag.png
Kannalife Bolsters its Global Intellectual Property Portfolio with New Chinese-Issued Patent
18 févr. 2020 09h00 HE | Kannalife, Inc.
DOYLESTOWN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company specializing in the research and development of...